JKS logo
  Jouhou Koukai Services LLC

READING ROOM



formatting


Regulatory & Commercial News >>

2009 >>


December 29, 2009: Flu pandemic in Japan update (6): The MHLW MHLW Headoffice in TokyoMHLW Headoffice in Tokyo to revise the Preventive Vaccination Law in order to allow the use of public funds to cover vaccination expenses even for the lowest income earners; at the Tokyo Stock Exchange (TSE) Tokyo Stock Exchange (TSE)Tokyo Stock Exchange (TSE) shares of Shionogi Seiyaku KK Shionogi Seiyaku headoffice in OsakaShionogi Seiyaku headoffice in Osaka rose markedly on the projected market launch of Peramivir (neuraminidase inhibitor), discovered by BioCryst Pharmaceuticals, Inc. BioCryst Pharmaceuticals logoBioCryst Pharmaceuticals logo for treatment of influenza; the Pharmaceutical Affairs and Food Sanitation Council (PAFSC) of MHLW gave a conditional pre-approval for two foreign anti-flu vaccines imported by GlaxoSmithKline Japan KK GSK headoffice in TokyoGSK headoffice in Tokyo and Novartis Pharma KK Novartis Pharma KK logoNovartis Pharma KK logo , decision expected by February 2010 ... Anti-flu products in JAD Databases
December 28, 2009: JKS News: In 2009 the Japanese pharmaceutical industry and market grew slowly but steadily from the initial $66.7 billion in January 2009 (IMS Health data) ... Industry consulting and market assessment
December 17, 2009: Generics News: The Central Social Insurance Medical Council (CSIMC) CSIMC meeting (archival photo)CSIMC meeting (archival photo) approved a provision for paying higher fees to pharmacies dispensing generics in more than 25% of sales volume; the JV company Teva-Kowa Pharma KK Building with the Headquarters of Teva Pharmaceuticals KK in TokyoMylan Japan headoffice to launch in January 37 new generics; Mylan KK Building with the Headquarters of Teva Pharmaceuticals KK in TokyoMylan Japan headoffice announced plans to market bio-generics in Japan from 2013 ... Generics in JAD Databases | Generics report preview
December 16, 2009: JKS News: Medipal Holdings KK Medipal Holdings headoffice building in TokyoMedipal Holdings headoffice building in Tokyo reported to build 210 billion Yen a year OTC drug distribution center to serve Greater Tokyo area ... OTC consulting
December 12, 2009: Flu pandemic in Japan update (5): The National Institute of Infectious Diseases (NIID) NIIDNIID estimated the number of flu-affected patients in Japan to have exceeded 12.6 million with the number of fatalities to reach 100; at the Tokyo Stock Exchange (TSE) Tokyo Stock Exchange (TSE)Tokyo Stock Exchange (TSE) shares of Daiichi-Sankyo KK Daiichi-Sankyo brandmarkDaiichi-Sankyo brandmark rose after the announcement for successful completion of clinical trials of Laninamivir; Chugai Seiyaku KK Chugai Seiyaku headoffice in Mitsui Honkan BldgChugai Seiyaku headoffice in Mitsui Honkan Bldg stock price decreased after the unexpected drop of the weekly number of new infections; low-scale survey by Medical Oblige KK found that only one fifth of the physicians have been able to provide immunization to all of their assigned priority patients ... Anti-flu products in JAD Databases
December 9-11, 2009: JKS News: The Drug Price Subcommittee of the Central Social Insurance Medical Council (CSIMC) CSIMC meeting (archival photo)CSIMC meeting (archival photo) held held a meeting to deliberate on the request by the Ministry of Finance (MOF) Ministry of Finance headofficeMinistry of Finance headoffice for a 30 billion Yen cut of reimbursement budget; on proposed price protection for 10 years after approval for all patented drugs; introduction of new drugs and off-label use of approved pharmaceuticals, and prices for products intended for long-term administration ... Drug price services | Report preview
December 7, 2009: JKS News: The President of the Japan Self-Medication Industry and President of SS Seiyaku KK, announced that OTC trade group plans to establish Asian regional association in mid 2010 ...
November 30, 2009: JKS News: In a move to attract foreign applicants, the MHLW MHLW Headoffice in TokyoMHLW Headoffice in Tokyo is expected to decide on whether to introduce a price protection for 10 years after approval for all patented drugs thus avoiding the biannual price reduction ... Pricing & Reimbursement consulting
November 27, 2009: JKS News: A new comprehensive, lawmaker-initiated bill to subsidize all hepatitis patients passed the Lower House vote, endorsement by the Upper House expected shortly ... Previous hepatitis news | Epidemiology consulting and data | Hepatitis reports | Related sources |
November 23, 2009: Flu pandemic in Japan update (5): Over 9 millions is the number of people in Japan who have contracted A/H1N1 influenza since early July according to National Institute of Infectious Diseases (NIID) NIIDNIID ; GlaxoSmithKline Japan KK GSK headoffice in TokyoGSK headoffice in Tokyo has informed the authorities about the suspension of its A/H1N1 influenza vaccination in Canada due to higher rate of side effects; the MHLW MHLW Headoffice in TokyoMHLW Headoffice in Tokyo is sending a fact-finding mission in December GSK products in JAD Databases | Epidemiology consulting and data...
November 21, 2009: Pfizer KK Pfizer Japan headoffice building in TokyoPfizer Japan headoffice building in Tokyo announced plan to enter the Japanese generics market in 2011 with goal of launching nearly 100 products; post-Wyeth reorganization of research facilities world-wide does not affect Japan operation ... previous Pfizer news | Pfizer products in JAD Databases
November 20, 2009: JKS News: The Government Revitalization Unit completed the first round of 3 trillion Yen budget cut review by requesting the abolishment of wasteful projects for 1.3 trillion Yen; all deliberation of the panel were held in an open for the public hall and broadcasted live on Internet ... Policy consulting
November 19, 2009: Flu pandemic in Japan update (4): The National Institute of Infectious Diseases (NIID) NIIDNIID estimated the number of flu patients in Japan to have exceeded 1.6 million; the MHLW MHLW Headoffice in TokyoMHLW Headoffice in Tokyo approved a single-shot vaccination scheme for the new A/H1N1 influenza; ordered packaging of domestically-produced vaccine in 1 mL vials, instead of current 10 mL; Shionogi Seiyaku KK Shionogi Seiyaku headoffice in OsakaShionogi Seiyaku headoffice in Osaka submitted a NDA in Japan for i.v. Peramivir (neuraminidase inhibitor), discovered by BioCryst Pharmaceuticals, Inc. BioCryst Pharmaceuticals logoBioCryst Pharmaceuticals logo for treatment of influenza; Novartis Pharma KK Novartis Pharma KK logoNovartis Pharma KK logo has submitted for approval Celtura - a cell-based vaccine against new influenza A/H1N1, containing MF59 adjuvant ...
November 18, 2009: JKS News: The reformed Central Social Insurance Medical Council (CSIMC) CSIMC meeting (archival photo)CSIMC meeting (archival photo) - now free from the pressure of special-interest groups such as the Japan Medical Association Japan Medical Association HeadofficeJapan Medical Association Headoffice opened discussion on the revision of medical treatment fees and drug reimbursement cuts planned for April 2010 ... CSIMC consulting services
November 16, 2009: JKS News: Eisai KK Eisai KK logoEisai KK logo President Haruo Naito Eisai KK NaitoEisai KK Naito to become first Japanese executive to head the The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) IFPMA logoIFPMA logo; Eisai announced the successful completion of Phase III study with E7389 (generic name: eribulin mesylate, “eribulin”), in patients with locally advanced or metastatic breast cancer; Eisai has concluded a strategic collaboration agreement with NovaQuest/Quintiles Quitiles HQ in Durham, North CarolinaQuitiles HQ in Durham, North Carolina to test six oncology candidate compounds for 18 indications; the first product after the acquisition of MGI Pharma MGI Pharma headofficeMGI Pharma headoffice - intravenous sedative agent Lusedra Injection to be launched in States ... Eisai products in JAD Databases | previous Eisai news
November 6, 2009: JKS News: The newly appointed Government Revitalization Unit panel announced over 300 state-funded projects as "wasteful", next to target the public agencies starting with the MHLW-affiliated Employment and Human Resources Development Organization of Japan MHLW Headoffice in TokyoMHLW Headoffice in Tokyo; a review on operational costs at PMDA PMDA Headoffice in TokyoPMDA Headoffice in Tokyo not yet on the agenda ... PMDA consulting
November 2, 2009: Astellas Seiyaku KK Astellas logoAstellas logo successfully licensed-in from Medivation Inc. Medivation logoMedivation logo the investigational drug MDV3100, a late clinical stage product intended for treatment of prostate cancer to upgrade its urology product line and to initiate an oncology franchise ... Astellas products in JAD Databases
October 26, 2009: Flu pandemic in Japan update (3): Only 7 out of the total 22,000 healthcare personnel vaccinated during the first week (October 19-23) of the nation-wide anti-flu campaign have shown side effects; the Infectious Disease Surveillance Center reported 830,000 new cases in the preceding week ...
October 19, 2009: Flu pandemic in Japan update (2): The mass vaccination against type A H1N1 flu starts today, as the MHLW opted for a single shot scheme; priority contingents: 1 million healthcare workers to be vaccinated first, followed by pregnant women and patients with specified chronic diseases; the Infectious Disease Surveillance Center reported 640,000 new cases in the preceding week with 27 fatalities; ... Vaccines in JAD Databases | Vaccine report preview
October 16, 2009: JKS News: The new Minister of Health, Labor and Welfare Mr. A. Nagatsuma Akira Nagatsuma, Minister of MHLWAkira Nagatsuma, Minister of MHLW , made his first drug approval of 18 new products, including Cervarix, domestically developed by GlaxoSmithKline KK Cervarix packagesCervarix packages - as the first in Japan vaccine for cervical pre-cancerous lesions related to HPV 16/18, pricing and market launch in December ... GSK KK products in JAD Databases | Anti-cancer drugs in JAD Databases | Report: Anti-cancers in Japan | Cancer epidemiology consulting and data
October 15-16, 2009: JKS News: The required anti-trust authorities world-wide provided Pfizer with clearance to complete the acquisition of Wyeth; Wyeth KK obtained approval for Prevnar vaccine against invasive pneumococcal disease (IPD) ... Wyeth products in JAD Databases | Vaccine report preview
October 12, 2009: The business daily Nihon Keizai Shimbun Nihon Keizai Shimbun HQNihon Keizai Shimbun HQ reported that Pfizer KK Pfizer Japan headoffice building in TokyoPfizer Japan headoffice building in Tokyo is planning to resume drug investigation in Japan in a surprise move after closing the Japanese research facility in 2008 ... previous Pfizer news Pfizer products in JAD Databases
October 5, 2009: In Nihon Keizai Shimbun Nihon Keizai Shimbun HQNihon Keizai Shimbun HQ ranking of stock performance of all 14 IPO firms in January-September period, drug makers and medical service companies top the list as the GI-focused Taiko Pharmaceutical KK price gained 400% ... Gastrointestinal products in JAD Databases
October 2, 2009: Flu pandemic update: The Chief Cabinet Secretary H. Hirano announced that the Government shall procure 77 millions doses of the new A/H1N1 influenza vaccine thus covering considerably more percentage of the population WHO predicted global ratio of 3 out of 6.7 billions people; the four domestic manufactures to have at most 19 millions dose output; the vaccination under the Preventive Vaccination Law shall start on October 19 with the highest risk contingents; an envisaged special measures law indemnifying patients suffering from side effects of the vaccine and exempting foreign makers from side effects liability related to emergency imported vaccines, is yet to be adopted; stockpile of anti-flu medications (Tamiflu, Relenza) is currently sufficient for 50 millions people; the death tall reached 15 cases, the youngest 12-year old ... Vaccines in JAD Databases | Vaccine report preview
October 1, 2009: JKS News: The Tokyo High Court Tokyo District CourtTokyo District Court overturned the 2007 ruling of Tokyo District Court the government policy of restricting the mixed treatment co-payment has no legal basis ... Reimbursement and health insurance info consulting services


News archive (2012-2006)>>

 

Archived headline news from other periods could be found here:


Notice >>

 

The JAD News Database is currently in beta-testing and expected to be launched in 2011 for all registered users


Registered users of JAD Databases>>


JAD users login button


Copyright © 2001-2013 and Database Rights owned by Jouhou Koukai Services LLC. All rights reserved worldwide.
All materials on this web site are protected by copyrights. Jouhou Koukai and Jouhou Koukai logo are service marks of JKS LLC.

Terms & Conditions | Inquiries to Regulatory Department